SEROPREVALENCE OF ANTI-TOXOPLASMA GONDII ANTIBODIES IN THE MOST CONSUMED LIVESTOCK AND POULTRY IN GAZA – PALESTINE

نویسندگان

چکیده

It is commonly established that warm blooded animals are extremely vulnerable to the infectious coccidian parasite, Toxoplasma gondii. T. gondii can be transmitted poultry and livestock through ingestion of oocyst (fecal-oral), placenta (congenital toxoplasmosis) in livestock. Cattle, sheep, rabbits some most consumed Palestine. As for poultry, backyard chicken, caged turkeys birds. The aim present study detect seroprevalence Anti-T. antibodies (IgG/IgM) among frequently which collected from farms slaughterhouses Gaza, For this specific study, blood samples 213 cattle, 100 99 were collected. On other hand, 50 each type mentioned above also criteria collection based on a quick survey was performed animal breeders owners area, under guidance colleagues Palestinian Ministry Agriculture (veterinary department), as well with support documented references targeted groups suitable meat production regardless age gender. analyzed use ELISA technique Rapid Cassette Test. results showed high 64.00 % 13.14% cattle. chicken 26.00% 2.00%, respectively. However, no detected serum turkeys.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anti-Toxoplasma gondii Antibodies in Haemodialysis Patients

Problem statement: In situations of immunodeficiency, Toxoplasma gondii emerges as a life-threatening infection. Toxoplasma gondii is transmitted parenterally, flourish in immunocompromised subjects and, most toxoplasma infections are asymptomatic. Studies have shown that there is a immunodeficiency in renal failure patient such as hemodialysis patients and these patients have a high risk for m...

متن کامل

Seroprevalence of Toxoplasma gondii antibodies in wild carnivores from Spain.

Serum samples from 282 wild carnivores from different regions of Spain were tested for antibodies to Toxoplasma gondii by the modified agglutination test using a cut-off value of 1:25. Antibodies to T. gondii were found in 22 of 27 (81.5%) of Iberian lynx (Lynx pardinus), 3 of 6 European wildcats (Felis silvestris), 66 of 102 (64.7%) red foxes (Vulpes vulpes), 15 of 32 (46.9%) wolves (Canis lup...

متن کامل

Seroprevalence of anti-Toxoplasma gondii antibodies in Egyptian sheep and goats

BACKGROUND Toxoplasmosis is a zoonotic disease that affects a wide range of animals, including small ruminants. Sheep and goats are considered as biological indicators for the contamination of the environment with Toxoplasma gondii oocysts. In addition, in countries such as Egypt, where sheep and goat meat is frequently consumed, T. gondii infection in small ruminants may also pose a public hea...

متن کامل

Survey on Seroprevalence of Anti-Toxoplasma Gondii Antibodies in Cattle in Tabriz (Iran) by IFAT

Toxoplasmosis is a zoonotic disease in various species of animals caused by a sporozoan parasite, Toxoplasma gondii. The disease occurs throughout the world including Iran. This disease is a common infection of sheep, goats and it is recognized as one of major infection cause of reproductive failure. This survey was carried out to show the prevalence of this disease in cattle in Tabriz (Iran). ...

متن کامل

SEROPREVALENCE OF TOXOPLASMA ANTIBODIES AMONG PREGNANT WOMEN IN KERMAN SHAH

Sera from 495 pregnant women were examined for toxoplasma antibodies by indirect fluorescent antibody testing (IFAT). Antibodies were positive in 32.7%. Seropositivity was not increased significantly with age but showed a statistically significant rise in accordance with frequency of parity, abortion and contact with cats. The high rate of seronegativity (67.3%) observed in pregnant women ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: IUG Journal of Natural Studies

سال: 2022

ISSN: ['2409-4587', '2410-292X']

DOI: https://doi.org/10.33976/iugns.30.1/2022/3